Sujuan Gao1, Frederick W Unverzagt2, Kathleen S Hall2, Kathleen A Lane3, Jill R Murrell4, Ann M Hake5, Valerie Smith-Gamble6, Hugh C Hendrie7. 1. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN. Electronic address: sgao@iupui.edu. 2. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN. 3. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN. 4. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN. 5. Department of Neurology, Indiana University School of Medicine, Indianapolis, IN; Department of Neurology, Indiana University, Indianapolis, IN. 6. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN; Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN. 7. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN; Indiana University Center for Aging Research, Indianapolis, IN; Regenstrief Institute, Inc., Indianapolis, IN.
Abstract
OBJECTIVE: To examine the long-term outcomes of community-based elderly African Americans by following their transitions from normal cognition to mild cognitive impairment (MCI) to dementia. METHODS: Participants were from the community-based Indianapolis Dementia Project. A total of 4,104 African Americans were enrolled in 1992 or 2001 and followed until 2009 with regularly scheduled evaluation of cognitive assessment. A two-stage sampling was used at each evaluation to select individuals for extensive clinical assessment following the results of Stage 1 cognitive testing. Age- and gender-specific incidence, progression, and reversion rates for MCI were derived using the person-year method in a dynamic cohort and predicted probabilities from weighted multinomial logistic models of transitional probabilities among normal cognition, MCI, and dementia. RESULTS: Annual overall incidence rate for MCI was 5.6% (95% confidence interval [CI]: 4.6%-6.6%). Annual progression rate from MCI to dementia was 5.9% (95% CI: 5.3%-6.5%), and annual reversion rate from MCI to normal was 18.6% (95% CI: 16.7%-20.4%). Both MCI incidence rates and MCI to dementia progression rates increased with age, whereas reversion rates from MCI to normal decreased with age. CONCLUSION: MCI progression to dementia was much more frequent in the older age groups than in younger participants where reversion to normal cognition is more common. Future research is needed to determine factors related to the heterogeneous outcomes in MCI individuals.
OBJECTIVE: To examine the long-term outcomes of community-based elderly African Americans by following their transitions from normal cognition to mild cognitive impairment (MCI) to dementia. METHODS:Participants were from the community-based Indianapolis Dementia Project. A total of 4,104 African Americans were enrolled in 1992 or 2001 and followed until 2009 with regularly scheduled evaluation of cognitive assessment. A two-stage sampling was used at each evaluation to select individuals for extensive clinical assessment following the results of Stage 1 cognitive testing. Age- and gender-specific incidence, progression, and reversion rates for MCI were derived using the person-year method in a dynamic cohort and predicted probabilities from weighted multinomial logistic models of transitional probabilities among normal cognition, MCI, and dementia. RESULTS: Annual overall incidence rate for MCI was 5.6% (95% confidence interval [CI]: 4.6%-6.6%). Annual progression rate from MCI to dementia was 5.9% (95% CI: 5.3%-6.5%), and annual reversion rate from MCI to normal was 18.6% (95% CI: 16.7%-20.4%). Both MCI incidence rates and MCI to dementia progression rates increased with age, whereas reversion rates from MCI to normal decreased with age. CONCLUSION: MCI progression to dementia was much more frequent in the older age groups than in younger participants where reversion to normal cognition is more common. Future research is needed to determine factors related to the heterogeneous outcomes in MCI individuals.
Authors: D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor Journal: JAMA Date: 1989-11-10 Impact factor: 56.272
Authors: Holly Tuokko; Robert Frerichs; Janice Graham; Kenneth Rockwood; Betsy Kristjansson; John Fisk; Howard Bergman; Al Kozma; Ian McDowell Journal: Arch Neurol Date: 2003-04
Authors: O Baiyewu; F W Unverzagt; A Ogunniyi; K S Hall; O Gureje; S Gao; K A Lane; H C Hendrie Journal: Eur J Neurol Date: 2002-11 Impact factor: 6.089
Authors: S Larrieu; L Letenneur; J M Orgogozo; C Fabrigoule; H Amieva; N Le Carret; P Barberger-Gateau; J F Dartigues Journal: Neurology Date: 2002-11-26 Impact factor: 9.910
Authors: F W Unverzagt; S Gao; O Baiyewu; A O Ogunniyi; O Gureje; A Perkins; C L Emsley; J Dickens; R Evans; B Musick; K S Hall; S L Hui; H C Hendrie Journal: Neurology Date: 2001-11-13 Impact factor: 9.910
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Joe Verghese; Emmeline Ayers; Nir Barzilai; David A Bennett; Aron S Buchman; Roee Holtzer; Mindy J Katz; Richard B Lipton; Cuiling Wang Journal: Neurology Date: 2014-10-31 Impact factor: 9.910
Authors: Mary M Machulda; Emily S Lundt; Sabrina M Albertson; Walter K Kremers; Michelle M Mielke; David S Knopman; Mark W Bondi; Ronald C Petersen Journal: Alzheimers Dement Date: 2019-05-23 Impact factor: 21.566
Authors: Mary Ganguli; Yichen Jia; Tiffany F Hughes; Beth E Snitz; Chung-Chou H Chang; Sarah B Berman; Kevin J Sullivan; M Ilyas Kamboh Journal: J Am Geriatr Soc Date: 2018-11-16 Impact factor: 5.562
Authors: M D López-Avalos; R Fernández-Llebrez Zayas; M Cifuentes; M V De Andrés; P Fernández-Llebrez Del Rey; J M Grondona; M Pérez-Martín; C Pedraza Journal: J Nutr Health Aging Date: 2015-10 Impact factor: 4.075
Authors: Kelsey R Thomas; Emily C Edmonds; Joel S Eppig; Christina G Wong; Alexandra J Weigand; Katherine J Bangen; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi Journal: Alzheimers Dement Date: 2019-09-05 Impact factor: 21.566
Authors: Melissa Lamar; Adeline León; Karina Romo; Ramon A Durazo-Arvizu; Shruti Sachdeva; Richard B Lipton; Krista M Perreira; Linda C Gallo; Jianwen Cai; Tasneem Khambaty; Jessica Carrasco; Maria M Llabre; Lisa T Eyler; Martha L Daviglus; Hector M González Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472